ImageneBio, Inc.IMAEarnings & Financial Report
Nasdaq
NextMar 13, 2026
IMA Q3 2025 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-26.6M
Net Profit
$-24.8M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-2.91
ImageneBio, Inc. Q3 2025 Financial Summary
ImageneBio, Inc. reported revenue of $0 for Q3 2025, with a net profit of $-24.8M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-24.8M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q3 2025 |
ImageneBio, Inc. Annual Revenue by Year
ImageneBio, Inc. annual revenue history includes year-by-year totals (for example, 2023 revenue was $9.2M).
| Year | Annual Revenue |
|---|---|
| 2023 | $9.2M |
| 2022 | $15.6M |
Income Statement
| Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q3 2024 | Q1 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.5M | $5.3M | $2.0M | $1.2M | $658000 | $3.5M | $800000 | $0 |
| YoY Growth | -73.0% | 57.0% | 424.6% | -81.5% | -87.9% | 195.4% | N/A | N/A |
Balance Sheet
| Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q3 2024 | Q1 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $172.3M | $152.4M | $171.8M | $215.3M | $192.1M | $149.0M | $130.8M | $160.9M |
| Liabilities | $25.3M | $17.4M | $15.1M | $28.1M | $22.3M | $14.8M | $12.6M | $21.0M |
| Equity | $147.0M | $135.0M | $156.7M | $155.3M | $169.8M | $134.2M | $118.3M | $139.8M |
Cash Flow
| Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q3 2024 | Q1 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-17.7M | $-19.8M | $-18.1M | $-20.0M | $-21.8M | $-8.9M | $-10.6M | $-26.6M |